300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Pakistan
Madagascar
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Truffle Capital, VC Fund

Truffle Capital

VC Fund

Paris, France

Truffle Capital is an independent, European venture capital firm focused on disruptive technologies in IT (FinTech and InsurTech) and Life Sciences (BioTech and MedTech). Truffle Capital aims to support the creation and growth of young innovative companies with the potential to become tomorrow’s market leaders. Chaired by Patrick Kron, alongsidethe company’s founders and CEOs, Philippe Pouletty and Bernard-Louis Roques, Truffle Capital raised over $1 billion and has supported over 75 companies since its creation, in the digital technologies and life sciences sectors.At the end of 2017, Truffle Capital successfully completed the first close of its two new institutional funds, Truffle Financial Innovation Fund and Truffle BioMedTech Fund, as well as the first close of a fund dedicated to the French Reserve Fund (« Fonds de Réserve pour les Retraites » or « FRF »).On May 2019, Truffle Capital is a company of 24 professionals from various nationalities (French, Italian, English, Chinese…), passionated by the trade of financing innovation.

Total investments:
60
Last investment:
Lead investor:
52%
Fund size:
$156M
Last fund:

Last updated:

Industries Truffle Capital invests in

BiotechnologyFinancial ServicesHealth CareSoftwareFinTech

Stages Truffle Capital invests in

Funding RoundSeries ASeries BSeedSeries C

Countries Truffle Capital invests in

FranceUnited StatesBelgiumSwitzerlandThe Netherlands

Round sizes

Series A $2.2M–$13MSeries B $3.3M–$50M

Contacts

NameEmailPhoneSocials
See all 11 contacts →

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2.2M–$13M
Series B
$3.3M–$50M

Investment Focus

Industry

  • Biotechnology 13 (22%)
  • Financial Services 11 (18%)
  • Health Care 9 (15%)
  • Software 8 (13%)
  • FinTech 7 (12%)
See all 72 industries →

Stage

  • Funding Round 15 (25%)
  • Series A 14 (23%)
  • Series B 11 (18%)
  • Seed 6 (10%)
  • Series C 3 (5%)
See all 10 stages →

Country

  • France 27 (45%)
  • United States 4 (7%)
  • Belgium 2 (3%)
  • Switzerland 2 (3%)
  • The Netherlands 2 (3%)
See all 11 countries →

Team

NameTitleInvestmentsLinksEmail
Antoine Pau
Antoine Pau Partner
Partner Total investments: 0
Find email
Faranaz Auliar
Faranaz Auliar Philippe Pouletty Executive Assistant
Philippe Pouletty Executive Assistant Total investments: 0 Find email
Jean-Claude Caducal
Jean-Claude Caducal CEO Circle, Life Sciences
CEO Circle, Life Sciences Total investments: 0 Find email
Michel Finance
Michel Finance Venture Partner
Venture Partner Total investments: 2
Find email
Miguel Sieler
Miguel Sieler Venture Partner
Venture Partner Total investments: 0
Find email
See all 11 team members →

Investments

CompanyDescriptionRoundLinks
Seacure Seacure
Géocorail développe et commercialise un produit innovant faisant travailler la mer à la protection du littoral : le Géocorail®. Ce procédé électrochimique breveté innovant consiste à créer une roche artificielle permettant de protéger les ouvrages marins et de lutter contre l’érosion du littoral. $8.5M / Venture - Series Unknown / Jun 08, 2026
Hydrosat Hydrosat
Hydrosat is a deep-tech company using thermal satellite data and AI to address society's most urgent challenges. We provide geospatial intelligence for food production, security, and natural resource management. $60M / Series B / Jan 15, 2026
Wyden Wyden
AlgoTrader is the global institutional leader in algorithmic trading and execution infrastructure for both digital and traditional assets. With its advanced software solutions, AlgoTrader gives banks, hedge funds, brokers, crypto funds and other financial institutions an end-to-end platform for best execution and event-driven alpha generation. Thecompany's offering includes WIRESWARM, a digital asset trading and connectivity platform for banks and brokers, AlgoTrader QUANT, an end-to-end quantitative trading solution with automated trade signal generation and order execution, and AlgoTrader OEMS, a state-of-the-art Order and Execution Management System for systematic and discretionary buy-side institutions with managed connectivity to over 400 liquidity venues. AlgoTrader’s interdisciplinary team of quantitative strategy developers, senior software engineers and financial and crypto experts is shaping institutional trading. Founded in Switzerland and based in Zurich, New York and Singapore, AlgoTrader operates globally. $16.9M / Series B / Nov 12, 2024
DgPays DgPays
Dgpays are into fintech which provides end-to-end payment system for Banks, E-Money Institutions, Telecom and Transportation Operators. $50M / Series B / Feb 27, 2024
Levenue Levenue
Levenue is built to help European founders with unlocking that value, positioning revenue as a new asset class. We are creating the largest European revenue-based finance marketplace that transforms recurring revenues into upfront cash instantly. We connect institutional investors with founders/ CFO’S on our platform. So that founders can getback to what really matters, focusing on their company. We provide recurring revenue companies with growth capital without diluting shareholders, or without the need for high consumer discounts, by leveraging on revenues. $8.7M / Series A / Nov 15, 2023
Obat Obat
Obat supplies contractors and independent contractors with invoicing software. The tool is constantly changing depending on input from customers and partners. $12.8M / Series A / Nov 09, 2023
MoneyTrack MoneyTrack
MoneyTrack is a global, decentralized blockchain platform for Directed Money. $2.2M / Series A / Jan 12, 2023
Obat Obat
Obat supplies contractors and independent contractors with invoicing software. The tool is constantly changing depending on input from customers and partners. $6M / Seed / Sep 18, 2022
Abivax Abivax
Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas. $49M / Post-IPO Equity / Sep 02, 2022
Bridge Bridge
Bridge is a banking data and payment system. They offer banking aggregation, payment initiation, open data, electronic invoices, debt collection, e-commerce sites and digital and physical commerce, factoring, kitty service, wallets, single and multiple payments, finance and insurance, credit, risk, and fraud experts. $20.3M / Series A / Jul 07, 2022
See all 60 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Sweden
Taiwan
Norway
Tajikistan
Tunisia
Liberia
Malawi
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Pakistan
Madagascar
Romania
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Andorra
Colombia
Sudan
China
Armenia
Czech Republic
Costa Rica
Kuwait
Kenya
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Seychelles
Moldova
Paraguay
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Truffle Capital invest in?

Truffle Capital invests primarily in Biotechnology, Financial Services and Health Care startups, most often at Funding Round and Series A stage. Most of the 60 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Truffle Capital's check size?

Truffle Capital typically joins rounds of $2.2M–$13M at Series A and $3.3M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Truffle Capital participates in.

How do I contact Truffle Capital?

Public channels for Truffle Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Truffle Capital?

The team at Truffle Capital includes Antoine Pau (Partner), Faranaz Auliar (Philippe Pouletty Executive Assistant) and Jean-Claude Caducal (CEO Circle, Life Sciences), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Truffle Capital Truffle Capital Find emails